Finland· FI-REL-REL2382
Neurolite
A technetium (99mtc) bicisate product containing bicisate dihydrochloride, registered in Finland by Lantheus MI UK Limited. The same ATC class is registered in 3 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Technetium (99mtc) bicisate is registered in 3 of 19 countries.
Countries holding a registration under ATC V09AA02 (technetium (99mtc) bicisate), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 2 of them publish a price we can compare per daily dose
Technetium (99mtc) bicisate · ATC V09AA02
3 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Bicisate dihydrochloride
- Manufacturer
- Lantheus MI UK Limited
- Country
- Finland (FI)
- ATC code
- V09AA02
- ATC class
- Technetium (99mTc) bicisate
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Technetium (99mtc) bicisate in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumNeuroliteLantheus EU
- CanadaNEUROLITELANTHEUS MI CANADA INC
- FranceNEUROLITE, trousse pour la préparation radiopharmaceutique : Injection de Bicisate de Technétium (99mTc)LANTHEUS EU (IRLANDE)
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Belgium · Neurolite
- Luxembourg · Neurolite
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4307d07d-f52b-459e-8f8d-9f2586b9e7e8 GET /v1/drugs/4307d07d-f52b-459e-8f8d-9f2586b9e7e8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektiokuiva-aine ja liuotin, liuosta varten",
"route": null,
"ddd_unit": null,
"strength": null,
"atc_label": "teknetium(99mTc)bisisaatti",
"ma_number": "11679",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL2382",
"authorised_at": "1995-02-27"
}See everything about technetium (99mtc) bicisate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.